Correlation Between Icares Medicus and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both Icares Medicus and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icares Medicus and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icares Medicus and SciVision Biotech, you can compare the effects of market volatilities on Icares Medicus and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icares Medicus with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icares Medicus and SciVision Biotech.
Diversification Opportunities for Icares Medicus and SciVision Biotech
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Icares and SciVision is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Icares Medicus and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Icares Medicus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icares Medicus are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Icares Medicus i.e., Icares Medicus and SciVision Biotech go up and down completely randomly.
Pair Corralation between Icares Medicus and SciVision Biotech
Assuming the 90 days trading horizon Icares Medicus is expected to under-perform the SciVision Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Icares Medicus is 1.01 times less risky than SciVision Biotech. The stock trades about -0.28 of its potential returns per unit of risk. The SciVision Biotech is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest 10,250 in SciVision Biotech on August 30, 2024 and sell it today you would lose (1,050) from holding SciVision Biotech or give up 10.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Icares Medicus vs. SciVision Biotech
Performance |
| Timeline |
| Icares Medicus |
| SciVision Biotech |
Icares Medicus and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icares Medicus and SciVision Biotech
The main advantage of trading using opposite Icares Medicus and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icares Medicus position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| Icares Medicus vs. Avalue Technology | Icares Medicus vs. Dadi Early Childhood Education | Icares Medicus vs. Golden Biotechnology | Icares Medicus vs. SynCore Biotechnology Co |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |